search
Back to results

Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant

Primary Purpose

Orbital Trauma, Orbital Fractures

Status
Completed
Phase
Phase 2
Locations
Singapore
Study Type
Interventional
Intervention
Osteosheet(r)
Sponsored by
National University Hospital, Singapore
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Orbital Trauma focused on measuring orbit, orbital, trauma, fractures, facial

Eligibility Criteria

20 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: age: 20 - 70 years facial trauma with orbital fractures Exclusion Criteria: No other coexistent conditions eg. diabetes, heart disease, etc

Sites / Locations

  • National University Hospital

Outcomes

Primary Outcome Measures

visual acuity
Enophthalmos
Diplopia
Cosmetic appearance

Secondary Outcome Measures

Full Information

First Posted
October 5, 2005
Last Updated
May 12, 2008
Sponsor
National University Hospital, Singapore
Collaborators
National Healthcare Group, Singapore
search

1. Study Identification

Unique Protocol Identification Number
NCT00233922
Brief Title
Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant
Official Title
Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant
Study Type
Interventional

2. Study Status

Record Verification Date
May 2008
Overall Recruitment Status
Completed
Study Start Date
July 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
National University Hospital, Singapore
Collaborators
National Healthcare Group, Singapore

4. Oversight

5. Study Description

Brief Summary
Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months. CT scan of the orbits are performed preop, 6 months & 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.
Detailed Description
Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months & 12 months. CT scan of the orbits are performed preop, 6 months & 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos & diplopia are assessed in follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Orbital Trauma, Orbital Fractures
Keywords
orbit, orbital, trauma, fractures, facial

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Osteosheet(r)
Primary Outcome Measure Information:
Title
visual acuity
Title
Enophthalmos
Title
Diplopia
Title
Cosmetic appearance

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age: 20 - 70 years facial trauma with orbital fractures Exclusion Criteria: No other coexistent conditions eg. diabetes, heart disease, etc
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thiam-Chye Lim, MBBS, FRCS
Organizational Affiliation
National University Hospital, Singapore
Official's Role
Principal Investigator
Facility Information:
Facility Name
National University Hospital
City
Singapore
ZIP/Postal Code
119074
Country
Singapore

12. IPD Sharing Statement

Learn more about this trial

Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant

We'll reach out to this number within 24 hrs